ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
Development of Leptin receptor-based technology and hybrid LNP platform Combining Blood-Brain Barrier penetration and a one-month sustained-release formulation in a single structure, with potential applications in CNS-targeted therapeutics Technology validated by winning first place in...
Covered in this story
What has happened since
- Lockheed Martin is down 2.4% since this was published, 58 days ago.
- Cohen & Steers Inc is down 15.0% since this was published, 58 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Lockheed Martin
- Bernstein: $522 → $564 by Oct 2027 · Market Perform via Stocktwits
- Rothschild & Co Redburn: $509 → $650 by Oct 2027 · Buy via Investing.com
- UBS: $536 → $674 by Sep 2027 · Buy via Seeking Alpha
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $LMT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Lockheed Martin →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.